Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Healthcare PE firm Altaris to acquire AI drug development outfit Simulations Plus for $375 million

17/06/2026 Published by Pharma Biz

Specialized healthcare private equity firm Altaris has entered into a definitive agreement to acquire Simulations Plus, a global leader in... Read more

Tags: #M&A

Merck & Co. enters $510 million AI drug discovery pact with Stanford spinout Protillion Biosciences

17/06/2026 Published by Pharma Biz

Global biopharmaceutical giant Merck & Co. has finalized a strategic multi-year licensing and research collaboration agreement with Protillion Biosciences. The... Read more

Category: Uncategorized

Tags: #Global Trends

FDA initiates review of Gilead’s once-weekly oral tablet for HIV PrEP application

17/06/2026 Published by Pharma Biz

The U.S. Food and Drug Administration (FDA) has officially commenced its formal regulatory review of Gilead Sciences’ once-weekly oral prescription... Read more

Category: Uncategorized

Tags: #Global Trends

Hacking group claims 1.3 terabyte data breach at Novo Nordisk following failed $25 million extortion attempt

17/06/2026 Published by Pharma Biz

A cyber extortion group has claimed to have exfiltrated over a terabyte of proprietary data from Danish pharmaceutical behemoth Novo... Read more

Category: Uncategorized

Tags: #Global Trends

FDA staff reviewers back Moderna’s flu shot data for accelerated older adult approval pathway

17/06/2026 Published by Pharma Biz

U.S. Food and Drug Administration staff reviewers announced on Tuesday that immunogenicity data tracking an active immune response to Moderna’s... Read more

Category: Uncategorized

Tags: #Global Trends

Moderna eyes manufacturing investments in Germany, targeting BioNTech’s planned facility closures

17/06/2026 Published by Pharma Biz

Moderna Chief Executive Officer Stephane Bancel told the German business daily Handelsblatt on Wednesday (June 17, 2026) that the United... Read more

Category: Uncategorized

Tags: #Global Trends

Edgewise heart drug clears Phase 2 trial milestone but faces investor skepticism over competitive edge

17/06/2026 Published by Pharma Biz

Colorado-based biotechnology firm Edgewise Therapeutics has announced that its investigational cardiovascular compound, EDG-7500, successfully met the primary objectives of its... Read more

Category: Uncategorized

Tags: #Global Trends

Eli Lilly accelerates M&A streak with acquisition of non-opioid pain drug developer 4E Therapeutics

17/06/2026 Published by Pharma Biz

U.S. pharmaceutical titan Eli Lilly and Company has announced a definitive agreement to acquire 4E Therapeutics, a biotechnology startup specializing... Read more

Category: Uncategorized

Tags: #M&A